NYSE · Diagnostics & Research

Charles River Laboratories (CRL)

$295.19 +1.28%
76 Overbought Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$190.03+55.34%

Company profile

Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.

SectorHealthcare
IndustryDiagnostics & Research
Market cap$13.58B
P/E ratioNone
EPS$-4.82
Beta1.376
Dividend yield0.00%
52-week high$287.95
52-week low$144.26

Similar stocks in Diagnostics & Research

Free forever

RSI alerts for CRL

Get an email the moment Charles River Laboratories crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 12 August 2026 at 10:28 PM EDT